Two Sigma Investments’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,741
Closed -$278K 3414
2025
Q1
$278K Buy
5,741
+83
+1% +$4.01K ﹤0.01% 2685
2024
Q4
$218K Sell
5,658
-53
-0.9% -$2.05K ﹤0.01% 2785
2024
Q3
$257K Sell
5,711
-76,926
-93% -$3.46M ﹤0.01% 2668
2024
Q2
$2.86M Sell
82,637
-74,957
-48% -$2.6M 0.01% 1253
2024
Q1
$4.56M Sell
157,594
-1,249
-0.8% -$36.1K 0.01% 969
2023
Q4
$3.64M Sell
158,843
-177,465
-53% -$4.07M 0.01% 1093
2023
Q3
$5.61M Sell
336,308
-40,165
-11% -$670K 0.02% 796
2023
Q2
$10.4M Buy
376,473
+68,773
+22% +$1.9M 0.03% 590
2023
Q1
$7.08M Sell
307,700
-184,265
-37% -$4.24M 0.02% 699
2022
Q4
$5.37M Buy
491,965
+246,260
+100% +$2.69M 0.02% 788
2022
Q3
$2.07M Sell
245,705
-69,939
-22% -$590K 0.01% 1097
2022
Q2
$2.5M Buy
315,644
+27,126
+9% +$215K 0.01% 1025
2022
Q1
$6.83M Buy
288,518
+260,418
+927% +$6.17M 0.02% 759
2021
Q4
$961K Buy
28,100
+3,500
+14% +$120K ﹤0.01% 1675
2021
Q3
$436K Sell
24,600
-48,777
-66% -$865K ﹤0.01% 2058
2021
Q2
$3.29M Sell
73,377
-10,139
-12% -$455K 0.01% 1100
2021
Q1
$2.16M Sell
83,516
-72,850
-47% -$1.89M 0.01% 1230
2020
Q4
$3.15M Sell
156,366
-63,837
-29% -$1.29M 0.01% 898
2020
Q3
$4.31M Sell
220,203
-69,775
-24% -$1.36M 0.02% 660
2020
Q2
$5.12M Buy
289,978
+180,355
+165% +$3.19M 0.03% 531
2020
Q1
$774K Sell
109,623
-94,261
-46% -$666K 0.01% 1070
2019
Q4
$1.44M Buy
203,884
+154,463
+313% +$1.09M ﹤0.01% 1243
2019
Q3
$594K Sell
49,421
-72,703
-60% -$874K ﹤0.01% 1389
2019
Q2
$1.48M Buy
122,124
+76,247
+166% +$923K ﹤0.01% 1200
2019
Q1
$577K Sell
45,877
-11,301
-20% -$142K ﹤0.01% 1605
2018
Q4
$385K Sell
57,178
-87,341
-60% -$588K ﹤0.01% 1658
2018
Q3
$1.49M Sell
144,519
-32,960
-19% -$339K ﹤0.01% 1215
2018
Q2
$1.19M Buy
177,479
+144,679
+441% +$973K ﹤0.01% 1292
2018
Q1
$282K Sell
32,800
-24,976
-43% -$215K ﹤0.01% 1755
2017
Q4
$1.2M Buy
+57,776
New +$1.2M ﹤0.01% 1374